The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
A protective function for interleukin 17A in T cell–mediated intestinal inflammation
Open accessAbstract
Interleukin 23 (IL-23) and IL-17 have been linked to the pathogenesis of several chronic inflammatory disorders, including inflammatory bowel disease. Yet as an important function for IL-23 is emerging, the function of IL-17 in inflammatory bowel disease remains unclear. Here we demonstrate IL-17A-mediated protection in the CD45RBhi transfer model of colitis. An accelerated wasting disease elicited by T cells deficient in IL-17A correlated with higher expression of genes encoding T helper type 1-type cytokines in colon tissue. IL-17A also modulated T helper type 1 polarization in vitro. Furthermore, T cells deficient in the IL-17 receptor elicited an accelerated, aggressive wasting disease relative to that elicited by wild-type T cells in recipient mice. Our data demonstrate a protective function for IL-17 and identify T cells as not only the source but also a target of IL-17 in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Given that IL-17A- and IL-22-producing Th17 cells appear to be protective rather than pathogenic in the intestines (84)”
From T H 17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity (2020) · cites this paper as [84]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K. P., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,819
Interleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,371
Self-citationInterleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P. A., Kasman, I. M., Eastham‐Anderson, J., Wu, J., & Ouyang, W. (2006) · Nature · doi:10.1038/nature05505 · Cited by 1,888
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,848
Increased expression of interleukin 17 in inflammatory bowel disease
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., & Fujiyama, Y. (2003) · Gut · doi:10.1136/gut.52.1.65 · Cited by 1,713
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 756
Silva‐Filho, J. L., de Souza, M. C., Ferreira-DaSilva, C. T., Silva, L. S., Costa, M. F. D. S., Pádua, T. A., Henriques, M. D. G., Morrot, A., Savino, W., Caruso‐Neves, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062999 · Cited by 35
IL-17-expressing cells as a potential therapeutic target for treatment of immunological disorders
Strzępa, A., & Szczepanik, M. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70396-6 · Cited by 33
Distinct Roles for CXCR6+ and CXCR6− CD4+ T Cells in the Pathogenesis of Chronic Colitis
Mandai, Y., Takahashi, D., Hase, K., Obata, Y., Furusawa, Y., Ebisawa, M., Nakagawa, T., Satô, T., Katsuno, T., Saitō, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065488 · Cited by 33
Severe de novo Ulcerative Colitis following Ixekizumab Therapy
Philipose, J., Ahmed, M., Idiculla, P. S., Mulrooney, S., & Gumaste, V. V. (2018) · Case Reports in Gastroenterology · doi:10.1159/000493922 · Cited by 33
Two functionally distinct subsets of IL‐17 producing γδ T cells
O’Brien, R. L., & Born, W. K. (2020) · Immunological Reviews · doi:10.1111/imr.12905 · Cited by 35
An epigenome‐wide DNA methylation study of patients with COVID‐19
Zhou, S., Zhang, J., Xu, J., Zhang, F., Li, P., He, Y., Wu, J., Wang, C., Wang, X., Zhang, W., et al. (2021) · Annals of Human Genetics · doi:10.1111/ahg.12440 · Cited by 33
Ogita, T., Nakashima, M., Morita, H., Saito, Y., Suzuki, T., & Tanabe, S. (2011) · BioMed Research International · doi:10.1155/2011/378417 · Cited by 33
Horie, I., Abiru, N., Saitoh, O., Ichikawa, T., Iwakura, Y., Eguchi, K., & Nagayama, Y. (2010) · Autoimmunity · doi:10.3109/08916931003777247 · Cited by 33
Self-citationBrabec, T., Vobořil, M., Schierová, D., Valter, E., Šplíchalová, I., Dobeš, J., Březina, J., Dobešová, M., Aidarova, A., Jakubec, M., et al. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2023.01.005 · Cited by 31
Whatʼs the next best cytokine target in IBD?
MacDonald, T. T., Biancheri, P., Sarra, M., & Monteleone, G. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22967 · Cited by 32
Lu, P., Struijs, M.-C., Mei, J., Witte‐Bouma, J., Male, A. M. K.-V., de Bruijn, A. C. J. M., van Goudoever, J. B., & Renes, I. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078491 · Cited by 33
Germ-Free Conditions Modulate Host Purine Metabolism, Exacerbating Adenine-Induced Kidney Damage
Mishima, E., Ichijo, M., Kawabe, T., Kikuchi, K., Akiyama, Y., Toyohara, T., Suzuki, T., Suzuki, C., Asao, A., Ishii, N., et al. (2020) · Toxins · doi:10.3390/toxins12090547 · Cited by 32
Fong, D. J., Hogaboam, C. M., Matsuno, Y., Akira, S., Uematsu, S., & Joshi, A. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03219.x · Cited by 33
Coventry, B. J., & Ashdown (2012) · Cancer Management and Research · doi:10.2147/cmar.s31887 · Cited by 31
Moran, E. M., & Mastaglia, F. L. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2014.06.432 · Cited by 32
Defining the functional states of Th17 cells
Lee, Y., & Kuchroo, V. K. (2015) · F1000Research · doi:10.12688/f1000research.6116.1 · Cited by 32
Contextual functions of antigen‐presenting cells in the gastrointestinal tract
Grainger, J. R., Askenase, M. H., Guimont‐Desrochers, F., da Fonseca, D. M., & Belkaid, Y. (2014) · Immunological Reviews · doi:10.1111/imr.12167 · Cited by 32
López-Posadas, R., Fastancz, P., Martínez-Sánchez, L. D. C., Panteleev-Ivlev, J., Thonn, V., Kisseleva, T., Becker, L. S., Schulz-Kuhnt, A., Zundler, S., Wirtz, S. J., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.07.007 · Cited by 31
Nishiguchi, R., Basu, S., Staab, H. A., Ito, N., Zhou, X. K., Wang, H., Ha, T., Johncilla, M. E., Yantiss, R. K., Montrose, D. C., et al. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab007 · Cited by 31
Cytokine IL9 Triggers the Pathogenesis of Inflammatory Bowel Disease Through the miR21-CLDN8 Pathway
Li, L., Huang, S., Wang, H., Chao, K., Ding, L., Feng, R., Qiu, Y., Feng, T., Zhou, G., Hu, J., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy187 · Cited by 31
Function of Act1 in IL-17 Family Signaling and Autoimmunity
Wu, L., Zepp, J. A., & Li, X. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0106-3_13 · Cited by 32
Mathews, J. A., Kasahara, D. I., Ribeiro, L., Wurmbrand, A. P., Ninin, F. M. C., & Shore, S. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131236 · Cited by 31
γδ T Cell Receptors without a Job
Kapsenberg, M. L. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.004 · Cited by 30
Reciprocity in Microbiome and Immune System Interactions and its Implications in Disease and Health
Nikoopour, E., & Singh, B. (2014) · Inflammation & Allergy - Drug Targets · doi:10.2174/1871528113666140330201056 · Cited by 31
Sato, K., Yamamoto, H., Nomura, T., Kasamatsu, J., Miyasaka, T., Tanno, D., Matsumoto, I., Kagesawa, T., Miyahara, A., Zong, T., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901238 · Cited by 29
Self-citationMorosi, L. G., Cutine, A. M., Cagnoni, A. J., Cocco, M. N. M., Croci, D. O., Merlo, J. P., Morales, R. M., May, M., Pérez‐Sáez, J. M., Girotti, M. R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf8630 · Cited by 30
Itk: The Rheostat of the T Cell Response
Grasis, J. A., & Tsoukas, C. D. (2011) · Journal of Signal Transduction · doi:10.1155/2011/297868 · Cited by 31
Niklasson, L. (2013) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 30
Are Th17 cells in the gut pathogenic or protective?
Symons, A., Budelsky, A., & Towne, J. E. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.51 · Cited by 29
Ordonez, L., Bernard, I., Chabod, M., Augusto, J., Lauwers‐Cancès, V., Cristini, C., Cuturi, M. C., Subra, J., & Saoudi, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069791 · Cited by 32
A Review of the Cytokine IL-17 in Ocular Surface and Corneal Disease
Garbutcheon‐Singh, K. B., Carnt, N. A., Pattamatta, U., Samarawickrama, C., White, A. J. R., & Calder, V. L. (2018) · Current Eye Research · doi:10.1080/02713683.2018.1519834 · Cited by 29
Takahara, M., Takaki, A., Hiraoka, S., Takei, K., Yasutomi, E., Igawa, S., Yamamoto, S., Oka, S., Ohmori, M., Yamasaki, Y., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202100831rr · Cited by 31
Brown, T. H. T., David, J., Acosta‐Ramírez, E., Moore, J. M., Lee, S., Zhong, G., Hancock, R. E. W., Xing, Z., Halperin, S. A., & Wang, J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.10.086 · Cited by 29
Conti, L., Palma, R. D., Rolla, S., Boselli, D., Rodolico, G., Kaur, S., Silvennoinen, O., Niccolai, E., Amedei, A., Ivaldi, F., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1004013 · Cited by 29
Ballal, S. A., Gallini, C. A., Segata, N., Huttenhower, C., & Garrett, W. S. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01572.x · Cited by 27
Th17 responses in Echinostoma caproni infections in hosts of high and low compatibility
Sotillo, J., Trelis, M., Cortés, A., Fried, B. N., Marcilla, A., Esteban, J. G., & Toledo, R. (2011) · Experimental Parasitology · doi:10.1016/j.exppara.2011.08.004 · Cited by 28
Coenzyme Q10 Inhibits Th17 and STAT3 Signaling Pathways to Ameliorate Colitis in Mice
Lee, S.-Y., Lee, S., Yang, E., Kim, J. K., Kim, E., Jung, K., Jung, H., Lee, K., Lee, H. H., Lee, B., et al. (2017) · Journal of Medicinal Food · doi:10.1089/jmf.2016.3859 · Cited by 28
Onac, I. A., Clarke, B. D., Tacu, C., Lloyd, M. E., Hajela, V., Batty, T., Thoroughgood, J., Smith, S., Irvine, H., Hill, D., et al. (2021) · Lara D. Veeken · doi:10.1093/rheumatology/keab193 · Cited by 28
Choi, G., Park, Y., Cho, M., Moon, H., Kim, D., Kang, C., Chung, Y., & Kim, B. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00632-9 · Cited by 29
Fine Mapping and Functional Analysis of the Multiple Sclerosis Risk Gene CD6
Swaminathan, B., Cuapio, A., Alloza, I., Matesanz, F., Alcina, A., García‐Barcina, M., Fedetz, M., Fernández, Ó., Lucas, M., Órpez, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062376 · Cited by 30
cis-Urocanic Acid Attenuates Acute Dextran Sodium Sulphate-Induced Intestinal Inflammation
Albert, E. J., Walker, J. W. T., Thiesen, A., Churchill, T. A., & Madsen, K. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013676 · Cited by 28
Toll-like receptor signaling directly increases functional IL-17RA expression in neuroglial cells
Liu, G., Guo, J. F., Liu, J., Wang, Z., & Liang, D. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.07.006 · Cited by 29
Ślebioda, T. J., Bojarska-Junak, A. A., Stanisławowski, M., Cyman, M., Wierzbicki, P., Roliński, J., Celiński, K., & Kmieć, Z. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12324 · Cited by 28
Bcl-3 deficiency protects against dextran-sodium sulphate-induced colitis in the mouse
O’Carroll, C., Moloney, G. M., Hurley, G., Melgar, S., Brint, E. K., Nally, K., Nibbs, R. J. B., Shanahan, F., & Carmody, R. J. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12119 · Cited by 27
Park, J., Park, B. L., Kim, M.-O., Heo, J.-S., Jung, J.-S., Bae, D.-J., Uh, S., Kim, M.-K., Choi, I. S., Cho, S., et al. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.11.002 · Cited by 27
Adamik, J., Henkel, M., Ray, A., Auron, P. E., Duerr, R. H., & Barrie, A. M. (2013) · Cytokine · doi:10.1016/j.cyto.2013.05.010 · Cited by 27
T Lymphocyte Autoreactivity in Inflammatory Mechanisms Regulating Atherosclerosis
Profumo, E., Buttari, B., Saso, L., Capoano, R., Salvati, B., & Riganò, R. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/157534 · Cited by 27
Pathogenic T cell subsets in allergic and chronic inflammatory bowel disorders
Zundler, S., & Neurath, M. F. (2017) · Immunological Reviews · doi:10.1111/imr.12544 · Cited by 26
Effective factors in the pathogenesis of Toxoplasma gondii
Nayeri, T., Sarvi, S., & Daryani, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31558 · Cited by 33
Storey, J., Gobbetti, T., Olzinski, A. R., & Berridge, B. R. (2021) · ILAR Journal · doi:10.1093/ilar/ilac004 · Cited by 27
Characterization of Autoreactive and Bystander IL-17 + T Cells Induced in Immunized C57BL/6 Mice
Nian, H., Liang, D., Zuo, A., Wei, R., Shao, H., Born, W. K., Kaplan, H. J., & Sun, D. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8297 · Cited by 26
Sidhu-Varma, M., Shih, D. Q., & Targan, S. R. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000653 · Cited by 26
Friedrich, M., Diegelmann, J., Beigel, F., & Brand, S. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000121 · Cited by 26
Pan, S., Zhang, K., Ding, X., Wang, J., Peng, H., Zeng, Q., Xuan, Y., Su, Z., Wu, B., & Bai, S. (2017) · Biological Trace Element Research · doi:10.1007/s12011-017-1060-9 · Cited by 26
Both IFN ‐γ and IL ‐17 are required for the development of severe autoimmune gastritis
Tu, E., Ang, D. K. Y., Bellingham, S. A., Hogan, T. V., Teng, M. W. L., Smyth, M. J., Hill, A. F., & van Driel, I. R. (2012) · European Journal of Immunology · doi:10.1002/eji.201142341 · Cited by 27
The ‘Treg paradox’ in inflammatory arthritis
Schnell, J. T., Briviesca, R. L., Kim, T., Charbonnier, L., Henderson, L. A., van Wijk, F., & Nigrovic, P. A. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01190-w · Cited by 27
Use of animal models in elucidating disease pathogenesis in IBD
Khanna, P. V., Shih, D. Q., Haritunians, T., McGovern, D. P. B., & Targan, S. R. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0444-6 · Cited by 25
Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease
Kim, Y., Chang, S., & Ko, H. (2015) · Intestinal Research · doi:10.5217/ir.2015.13.2.105 · Cited by 25
Epigenetic regulation of T helper cells and intestinal pathogenicity
Hagihara, Y., Yoshimatsu, Y., Mikami, Y., Takada, Y., Mizuno, S., & Kanai∥, T. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00732-9 · Cited by 25
T helper type 17 pathway suppression by appendicitis and appendectomy protects against colitis
Cheluvappa, R., Luo, A. S., & Grimm, M. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12237 · Cited by 25
Samson, M., Lakomy, D., Audia, S., & Bonnotte, B. (2010) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2009.12.020 · Cited by 29
Selected biologic markers of inflammation and activity of Crohn’s disease
Karczewski, J., Swora-Cwynar, E., Rzymski, P., Poniedziałek, B., & Adamski, Z. (2015) · Autoimmunity · doi:10.3109/08916934.2015.1016221 · Cited by 25
Hu, Y., Zhao, Q., Dai, H., Wu, Y., Tang, X., Zhang, N., Jiang, H., Rui, H., & Liu, B. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1687755 · Cited by 26
Ma, C., Jairath, V., Khanna, R., & Feagan, B. G. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1506764 · Cited by 23
Kim, H. I., Hong, S. H., Lee, S.-Y., Ku, J. M., Kim, M., & Ko, S. (2021) · Nutrients · doi:10.3390/nu13041349 · Cited by 25
Functional biomes beyond the bacteriome in the oral ecosystem
Girija, A. S. S., & Ganesh, P. S. (2022) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2022.05.002 · Cited by 27
Gut microbiome in type 1 diabetes: the immunological perspective
Rampanelli, E., & Nieuwdorp, M. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2150612 · Cited by 29
Kynurenine pathway and its role in neurologic, psychiatric, and inflammatory bowel diseases
Sheibani, M., Shayan, M., Khalilzadeh, M., Soltani, Z. E., Jafari‐Sabet, M., Ghasemi, M., & Dehpour, A. R. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08859-7 · Cited by 24
Adult Onset Still's Disease and Autoinflammation
Efthimiou, P., Moorthy, L. N., Mavragani, C. P., Skokos, D., & Fautrel, B. (2012) · International Journal of Inflammation · doi:10.1155/2012/964751 · Cited by 24
Combined Blockade of IL-17A and IL-17F May Prevent the Development of Experimental Colitis
McLean, L. P., Cross, R. K., & Shea‐Donohue, T. (2013) · Immunotherapy · doi:10.2217/imt.13.87 · Cited by 24
IL-17 is a protection effector against the adherent-invasive Escherichia coli in murine colitis
Zhang, H.-J., Xu, B., Wang, H., Xu, B., Wang, G., Jiang, M., Lei, C., Ding, M., Yu, P., Nie, Y., et al. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.11.020 · Cited by 24
Experimental colitis in IL-10-deficient mice ameliorates in the absence of PTPN22
Jofra, T., Galvani, G., Cosorich, I., Giorgi, L. D., Annoni, A., Vecchione, A. M., Sorini, C., Falcone, M., & Fousteri, G. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13339 · Cited by 24
IL-23 Gene Expression in PBMCs of Patients with Coronary Artery Disease
Khojasteh-Fard, M., Abolhalaj, M., Amiri, P., Zaki‐Dizaji, M., Taheri, Z., Qorbani, M., Tavakkoly‐Bazzaz, J., & Amoli, M. M. (2012) · Disease Markers · doi:10.1155/2012/629814 · Cited by 24
Bonavina, G., Mamillapalli, R., Krikun, G., Zhou, Y., Gawde, N., & Taylor, H. S. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03716-1 · Cited by 27
Chan, Y., Lai, W., Chen, J., Tseng, J. T.-C., Chuang, P.-C., Jou, J., Lee, C., & Sun, H. S. (2020) · Cancers · doi:10.3390/cancers12071844 · Cited by 23
Mechanisms and functions of IL-17 signaling in renal autoimmune diseases
Schmidt, T., Luebbe, J., Paust, H., & Panzer, U. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.09.005 · Cited by 23
Batoulis, H., Recks, M. S., Holland, F. O., Thomalla, F., Williams, R. O., & Küerten, S. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12209 · Cited by 23
Structural Basis of Neurohormone Perception by the Receptor Tyrosine Kinase Torso
Jenni, S., Goyal, Y., von Grotthuss, M., Shvartsman, S. Y., & Klein, D. E. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.026 · Cited by 22
RETRACTED ARTICLE: Mouse models of intestinal inflammation and cancer
Westbrook, A. M., Szakmary, A., & Schiestl, R. H. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1747-2 · Cited by 23
RetractedGao, Y., Wang, Y., Chauss, D., Villarino, A. V., Link, V. M., Nagashima, H., Spinner, C. A., Kopardé, V. N., Bouladoux, N. J., Abers, M. S., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01553-7 · Cited by 22
Valatas, V., He, J., Rivollier, A., Kolios, G. C., Kitamura, K., & Kelsall, B. L. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.102 · Cited by 22
Cytokine crowdsourcing: multicellular production of TH17-associated cytokines
Busman‐Sahay, K., Walrath, T., Huber, S., & O’Connor, W. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ru0814-386r · Cited by 24
Intestinal Organoids as a Novel Complementary Model to Dissect Inflammatory Bowel Disease
Schulte, L.-A., Hohwieler, M., Müller, M., & Klaus, J. (2019) · Stem Cells International · doi:10.1155/2019/8010645 · Cited by 22
Tachibana, M., Watanabe, N., Koda, Y., Oya, Y., Kaminuma, O., Katayama, K., Fan, Z., Sakurai, F., Kawabata, K., Hiroi, T., et al. (2019) · International Immunology · doi:10.1093/intimm/dxz076 · Cited by 22
Differential Modulation by IL-17A of Cholangitis versus Colitis in IL-2Rα Deleted Mice
Yang, W., Yao, Y., Yang, Y., Lu, F.-T., Li, L., Wang, Y., Nakajima, T., Tsuneyama, K., Ridgway, W. M., Gershwin, M. E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105351 · Cited by 21
Wang, R., & Maksymowych, W. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.715510 · Cited by 23
Blocking DCIR mitigates colitis and prevents colorectal tumors by enhancing the GM-CSF-STAT5 pathway
Sun, H., Tang, C., Chung, S.-H., Ye, X.-Q., Makusheva, Y., Han, W., Kubo, M., Shichino, S., Ueha, S., Matsushima, K., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111158 · Cited by 21
Self-citationImmune response modulation in inflammatory bowel diseases by Helicobacter pylori infection
Balani, G. F., Cortez, M. D. S., Freitas, J. E. P. D. S., de Melo, F. F., Zarpelon-Schutz, A. C., & Teixeira, K. N. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i30.4604 · Cited by 22
Treiner, E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00027 · Cited by 21
On The Role of Natural Killer Cells in Neurodegenerative Diseases
Maghazachi, A. A. (2013) · Toxins · doi:10.3390/toxins5020363 · Cited by 21
IL-22 exacerbates the severity of CVB3-induced acute viral myocarditis in IL-17A-deficient mice
Kong, Q., Xue, Y., Wu, W., Yang, F., Liu, Y., Gao, M., Lai, W., & Pan, X. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1323 · Cited by 21
Zhou, X., Johnson, J. S., Spakowicz, D. J., Zhou, W., Zhou, Y., Sodergren, E. J., Snyder, M. P., & Weinstock, G. M. (2020) · Diabetes · doi:10.2337/db19-0592 · Cited by 21
IEX-1 Deficiency Protects against Colonic Cancer
Ustyugova, I. V., Liang, Z., Abramowitz, J., Birnbaumer, L., & Wu, M. X. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0556 · Cited by 21
Review: New Anti-Cytokines for IBD: What is in the Pipeline?
Scharl, M. M., Vavricka, S. R., & Rogler, G. (2013) · Current Drug Targets · doi:10.2174/13894501113149990159 · Cited by 19
The safety of ixekizumab in psoriasis drug therapy
Puig, L. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2020.1709440 · Cited by 20
Crohn’s disease exacerbated by IL-17 inhibitors in patients with psoriasis: a case report
Ju, J., Dai, Y., Yang, J., Liu, C., Fan, L., Feng, L., Zhao, B., Zeng, M., Liu, Z., & Sun, X. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01474-x · Cited by 20
Pathophysiological Aspects of Ocular Toxoplasmosis: Host-parasite Interactions
Kalogeropoulos, D., Kalogeropoulos, C. D., Sakkas, H., Mohammed, B., Vartholomatos, G., Malamos, K., Sreekantam, S., Kanavaros, P., & de‐la‐Torre, A. (2021) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2021.1922706 · Cited by 20
Jia, X., Hu, M., Wang, C., Wang, C., Zhang, F., Han, Q., Zhao, R., Huang, Q., Xu, H., Yuan, H., et al. (2011) · PubMed Central · Cited by 20
Muzaki, A. R. B. M., Soncin, I., Setiagani, Y. A., Sheng, J., Tetlak, P., Karjalainen, K., & Ruedl, C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701053 · Cited by 21
Shim, Y. A., Weliwitigoda, A., Campbell, T., Dosanjh, M., & Johnson, P. (2020) · European Journal of Immunology · doi:10.1002/eji.202048687 · Cited by 20
Metadata
- Authors
- O'Connor Jr, W., Kamanaka, M., Booth, C. J., Town, T., Nakae, S., Iwakura, Y., Kolls, J. K., & Flavell, R. A.
- Affiliations
- Yale University (US)
- Cedars-Sinai Medical Center (US)
- Institute of Medical Science, The University of Tokyo (JP)
- Children's Hospital of Pittsburgh (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Flavell, Richard A
- Venue
- Nature Immunology
- Published
- 2009-05-17
- Volume
- 10
- Issue
- 6
- Pages
- 603-609
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC2709990
- OpenAlex
- W2069571875
- Cited by
- 756
- References
- 36
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 27 · 2023: 26 · 2022: 28 · 2021: 38 · 2020: 32 · 2019: 42 · 2018: 37 · 2017: 36 · 2016: 33 · 2015: 48 · 2014: 61 · 2013: 63 · 2012: 80
- FWCI
- 37.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute on Aging (R00AG029726)
- National Heart, Lung, and Blood Institute (R37HL079142)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-17A, IL-17 receptor, colitis, inflammatory bowel disease, IL-23, Th1 polarization, Th1 cytokines, wasting disease, protective immunity
- MeSH terms
- T-bet Transcription Factor, Animals, Cell Differentiation, Cells, Cultured, Colitis, Disease Models, Animal, Interferon-gamma, Lymphocyte Activation, Mice, Inbred BALB C, Leukocyte Common Antigens, Mice, Knockout, Th1 Cells, Adoptive Transfer, Wasting Syndrome, Interleukin-17, T-Box Domain Proteins, Gene Expression Profiling, Cell Proliferation, Mice, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review